Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| 1 |
Flutter Entertainment
FLUT
|
$849M |
| 2 |
Intuitive Surgical
ISRG
|
$559M |
| 3 |
CDW
CDW
|
$416M |
| 4 |
Philip Morris
PM
|
$408M |
| 5 |
PACCAR
PCAR
|
$325M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$1.92B |
| 2 |
TSMC
TSM
|
$789M |
| 3 |
Microsoft
MSFT
|
$708M |
| 4 |
JPMorgan Chase
JPM
|
$636M |
| 5 |
Eli Lilly
LLY
|
$561M |
Sector Composition
| 1 | Technology | 21.52% |
| 2 | Financials | 19.51% |
| 3 | Healthcare | 12.79% |
| 4 | Industrials | 12.47% |
| 5 | Consumer Discretionary | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNR
776
Burning Rock Biotech
BNR
$89.4M
| $1.26M | ﹤0.01% |
385,391
-5,809
| -1% | -$19K |
|
777
Playtika
PLTK
$1.4B
| $1.26M | ﹤0.01% |
158,608
-3,842
| -2% | -$30.4K |
|
778
Boise Cascade
BCC
$3.36B
| $1.26M | ﹤0.01% |
8,906
-23,033
| -72% | -$3.25M |
|
779
Arcus Biosciences
RCUS
$1.3B
| $1.24M | ﹤0.01% |
80,889
+22,716
| +39% | +$347K |
|
780
iShares Core MSCI Emerging Markets ETF
IEMG
$103B
| $1.23M | ﹤0.01% |
21,453
+1,200
| +6% | +$68.9K |
|
781
iShares Russell 1000 Growth ETF
IWF
$117B
| $1.21M | ﹤0.01% |
3,219
+974
| +43% | +$366K |
|
782
Copa Holdings
CPA
$4.85B
| $1.2M | ﹤0.01% |
12,768
+1,369
| +12% | +$128K |
|
783
Novavax
NVAX
$1.28B
| $1.18M | ﹤0.01% |
93,457
+18,229
| +24% | +$230K |
|
784
Vanguard ESG US Stock ETF
ESGV
$11.2B
| $1.17M | ﹤0.01% |
11,468
+6,323
| +123% | +$643K |
|
785
A-Mark Precious Metals
AMRK
$587M
| $1.16M | ﹤0.01% |
26,245
-10,151
| -28% | -$448K |
|
786
Anika Therapeutics
ANIK
$129M
| $1.15M | ﹤0.01% |
46,564
-1,127
| -2% | -$27.8K |
|
787
Prelude Therapeutics
PRLD
$69.6M
| $1.14M | ﹤0.01% |
549,530
+27,155
| +5% | +$56.2K |
|
788
Arcturus Therapeutics
ARCT
$485M
| $1.14M | ﹤0.01% |
48,957
+10,728
| +28% | +$249K |
|
789
Entrada Therapeutics
TRDA
$201M
| $1.11M | ﹤0.01% |
+69,394
| New | +$1.11M |
|
790
Cemex
CX
$13.6B
| $1.08M | ﹤0.01% |
176,539
+9,419
| +6% | +$57.5K |
|
791
MiMedx Group
MDXG
$1.06B
| $1.06M | ﹤0.01% |
178,932
-4,331
| -2% | -$25.6K |
|
792
Micron Technology
MU
$147B
| $1.02M | ﹤0.01% |
9,804
-968,389
| -99% | -$100M |
|
793
Workday
WDAY
$61.7B
| $1.02M | ﹤0.01% |
4,156
-21,376
| -84% | -$5.22M |
|
794
Voyager Therapeutics
VYGR
$235M
| $1.01M | ﹤0.01% |
171,856
+28,333
| +20% | +$166K |
|
795
Zymeworks
ZYME
$1.14B
| $1M | ﹤0.01% |
79,856
-1,933
| -2% | -$24.3K |
|
796
BioAtla
BCAB
$31.5M
| $1M | ﹤0.01% |
569,332
+28,133
| +5% | +$49.5K |
|
797
Lockheed Martin
LMT
$108B
| $967K | ﹤0.01% |
1,654
-10
| -0.6% | -$5.85K |
|
798
iShares ESG Aware MSCI EAFE ETF
ESGD
$9.93B
| $965K | ﹤0.01% |
11,462
+6,726
| +142% | +$566K |
|
799
Acadia Pharmaceuticals
ACAD
$4.26B
| $939K | ﹤0.01% |
61,051
-1,479
| -2% | -$22.7K |
|
800
Victoria's Secret
VSCO
$2.1B
| $926K | ﹤0.01% |
36,016
-44,722
| -55% | -$1.15M |
|